Cargando…
Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome
BACKGROUND: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. AIM: The objective of the study was to investigate whether angiopoietin-2 levels are associated...
Autores principales: | Rajendiran, Luxmipratha, Nandeesha, Hanumanthappa, Chitra, Thyagaraju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279058/ https://www.ncbi.nlm.nih.gov/pubmed/34316229 http://dx.doi.org/10.4103/jhrs.jhrs_179_20 |
Ejemplares similares
-
Laparoscopic Ovarian Drilling Reduces Testosterone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio and Improves Clinical Outcome in Women with Polycystic Ovary Syndrome
por: Sinha, Priyanka, et al.
Publicado: (2019) -
Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study
por: Kayali, Sreelalitha, et al.
Publicado: (2022) -
Comparison of Clinical, Metabolic, Hormonal, and Ultrasound Parameters among the Clomiphene Citrate-Resistant and Clomiphene Citrate-Sensitive Polycystic Ovary Syndrome Women
por: Sachdeva, Garima, et al.
Publicado: (2019) -
Matrix metalloproteinase-9 increases and Interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study
por: Sylus, Angel Mercy, et al.
Publicado: (2020) -
Metformin—clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
por: Ayaz, Aqueela, et al.
Publicado: (2013)